[OH:1][CH2:2][CH2:3][CH:4]1[NH:7][C:6](=[O:8])[CH2:5]1.[O:9]1[CH:14]=[CH:13][CH2:12][CH2:11][CH2:10]1.[OH2:15].[C:16]1(C)C=[CH:20][C:19](S(O)(=O)=O)=[CH:18][CH:17]=1>O1CCOCC1>[O:9]1[CH2:10][CH2:11][CH2:12][CH2:13][CH:14]1[N:7]1[CH:4]([CH2:3][CH2:2][O:1][CH:20]2[CH2:19][CH2:18][CH2:17][CH2:16][O:15]2)[CH2:5][C:6]1=[O:8]Under nitrogen and at 25° C., a solution of 4-(2-hydroxyethyl)-2-azetidinone (62 mg, 0.539 mmole) in 0.5 ml of anhydrous p-dioxane is treated with 2,3-dihydropyran (0.98 ml, 1.08 mmoles) and p-toluene sulfonic acid monohydrate (19 mg, 0.10 mmole). The resulting solution is stirred for a period of 60 minutes and then partitioned between 10 ml of 0.5M pH 7 phosphate buffer and 10 ml of ethyl acetate. The aqueous phase is extracted a second time with ethyl acetate. The combined ethyl acetate solutions are washed with brine, dried over magnesium sulfate and filtered. The filtrate is evaporated under reduced pressure to give 216 mg of crude product. Purification by preparative thick-layer chromatography developing with ethyl acetate gives 80 mg of 1-(2-tetrahydropyranyl)-4-[2-(2-tetrahydropyranyl)oxyethyl]-2-azetidinone as an oil.
Loading…
